Y-biologics Inc.

Jisu Lee

Young Woo Park

Bum-chan Park

Jae Eun Park

Young-Gyu Cho

Jung Chae Lim

Gi Sun Baek

Yeung Chul Kim

Si Hyung Lee

Seok Ho Yoo

Youngja Song

Hyun Mi Lee

Sunha Yoon

Ji-Young Shin

Yunseon Choi

Sang Pil Lee

Soo A Choi

Bum-Chan Park

The present invention relates to an antibody against delta-like 1 homolog () (DLK1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, an antibody drug conjugate (ADC) comprising the same, a pharmaceutical composition for treating cancer, a composition for diagnosing cancer, and a chimeric antigen receptor (CAR) and a T-cell engager comprising the same.

Antibody against human DLK1 and use thereof

Disclosed are an antibody to human programmed cell death-ligand 1 (PD-L1) or an antigen-binding fragment thereof, a nucleic acid encoding the same, a vector including the nucleic acid, a cell transformed with the vector, a method for producing the antibody or an antigen-binding fragment thereof, and a composition for preventing or treating cancer or infectious diseases containing the same.

Antibody to programmed death-ligand 1 (PD-L1) and use thereof

Growing community of inventors

Sejong, South Korea

Jisu Lee